Compass Therapeutics, Inc.
NASDAQ:CMPX
1.7 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 2.844 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 0.463 | 0.468 | 0.466 | 0.475 | 0.481 | 0.484 | 0.487 | 0.498 | 0.435 | 0.396 | 0.406 | 0.409 | 0.413 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| -0.463 | 2.376 | -0.466 | -0.475 | -0.481 | -0.484 | -0.487 | -0.498 | -0.435 | -0.396 | -0.406 | -0.409 | -0.413 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0 | 0.835 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 9.368 | 12.265 | 8.831 | 10.223 | 6.638 | 9.928 | 9.791 | 5.862 | 4.415 | 9.574 | 3.154 | 2.905 | 4.704 | 4.406 | 3.67 | 2.985 | 3.571 | 3.303 | 5.979 | 5.389 | 7.243 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 3.248 | 2.967 | 3.095 | 3.114 | 3.073 | 2.96 | 2.807 | 3.125 | 2.767 | 3.427 | 2.7 | 2.166 | 2.635 | 3.544 | 5.291 | 2.085 | 2.26 | 3.099 | 2.404 | 3.284 | 3.351 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| -0.309 | -0.307 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 2.939 | 2.66 | 3.095 | 3.114 | 3.073 | 2.96 | 2.807 | 3.125 | 2.767 | 3.427 | 2.7 | 2.166 | 2.635 | 3.544 | 5.291 | 2.085 | 2.26 | 3.099 | 2.404 | 3.284 | 3.351 | 0 | 0 | 0 |
| Overige kosten
| 1.983 | -1.874 | 0 | 0 | 1.874 | 0 | 0 | 0 | 0 | 50.618 | -0.044 | 50.618 | 0 | -18.42 | -8.952 | 0 | -2.228 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 12.307 | 14.925 | 11.926 | 13.337 | 9.711 | 12.888 | 12.598 | 8.987 | 7.182 | 13.001 | 5.854 | 5.071 | 7.339 | 7.95 | 8.961 | 5.07 | 5.831 | 6.402 | 8.383 | 8.673 | 10.658 | 0 | 0 | 0 |
| Bedrijfsresultaat
| -12.77 | -15.393 | -11.926 | -13.337 | -9.711 | -12.888 | -12.598 | -8.987 | -7.182 | -13.001 | -5.854 | -55.689 | -7.339 | -7.95 | -8.961 | -5.07 | -5.831 | -6.402 | -8.383 | -8.673 | -10.594 | 0 | 0 | 0 |
| Bedrijfsresultaat ratio
| 0 | -5.412 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 1.983 | 1.978 | 1.962 | 2.059 | 1.874 | 1.294 | 0.623 | 0.493 | 0.02 | 0.042 | -0.044 | -50.618 | 0.044 | -0.281 | 0.001 | -0.236 | -0.32 | -0.012 | -0.007 | -0.033 | -0.148 | 0 | 0 | 0 |
| Inkomen voor belasting
| -10.787 | -13.415 | -9.964 | -11.278 | -7.837 | -11.594 | -11.975 | -8.494 | -7.162 | -12.994 | -5.975 | -55.791 | -7.422 | -8.391 | -9.15 | -5.541 | -6.386 | -6.602 | -8.526 | -8.783 | -10.742 | 0 | 0 | 0 |
| Inkomen voor belasting ratio
| 0 | -4.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0.42 | 1.874 | 0.506 | 0.353 | -1.874 | -1.294 | -0.623 | -0.493 | -0.02 | -0.013 | 0.034 | 0.013 | 0.142 | 0.178 | 0.212 | 0.016 | 0.016 | 0.01 | 0.026 | 0.026 | 0.029 | 0 | 0 | 0 |
| Nettowinst
| -10.787 | -13.415 | -9.964 | -11.278 | -5.963 | -10.3 | -11.352 | -8.001 | -7.142 | -12.981 | -5.975 | -55.804 | -7.422 | -8.391 | -9.15 | -5.557 | -6.402 | -6.612 | -8.552 | -8.809 | -10.771 | 0 | 0 | 0 |
| Nettowinstmarge
| 0 | -4.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -0.079 | -0.11 | -0.078 | -0.089 | -0.047 | -0.098 | -0.11 | -0.079 | -0.071 | -0.25 | -0.097 | -1.07 | -0.14 | -0.14 | -0.15 | -0.11 | -0.12 | -0.11 | -0.16 | -0.17 | -2.15 | 0 | 0 | 0 |
| Verwaterde WPA
| -0.079 | -0.11 | -0.078 | -0.089 | -0.047 | -0.098 | -0.11 | -0.079 | -0.071 | -0.25 | -0.097 | -1.07 | -0.14 | -0.14 | -0.15 | -0.11 | -0.12 | -0.11 | -0.16 | -0.17 | -2.15 | 0 | 0 | 0 |
| EBITDA
| -12.307 | -14.925 | -11.46 | -12.862 | -9.23 | -11.11 | -11.488 | -8.065 | -6.727 | -12.601 | -5.491 | -4.653 | -6.911 | -6.863 | -8.504 | -4.626 | -5.327 | -5.785 | -7.668 | -8.436 | -10.068 | 0 | 0 | 0 |
| EBITDA ratio
| 0 | -5.248 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |